ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

This Small-Cap Healthcare Name Is Outperforming Its Index

  • Small-cap health staffing firm Cross Country Healthcare is notching price gains that outpace the broader market
  • The stock has a low number of shares in float, which means it can have wide intraday price swings. In recent months, that volatility has resulted in upside trade
  • The company has topped both sales and earnings expectations in every quarter since July 2019

This Small-Cap Healthcare Name Is Outperforming Its Index
Investors love to learn about companies like Cross Country Healthcare (NASDAQ: CCRN) with a long history of profitability, and revenue growth, and one that’s bucking the market’s downtrend. 

The Boca Raton, Florida company provides staffing and outsourcing services for health professionals, including travel nurses and temporary physicians.

If you’ve spent any time in hospital settings in the past decade or so, you’ve likely encountered some of these “freelance” professionals. I live in New Mexico, which has a relatively small population compared to other states. My family members and I have been treated by travel physicians and nurses. The level of care is exactly the same as if we’d been treated by a staff doctor or nurse. These professionals provide a service for short-staffed hospitals in various regions of the country. 

Cross Country Healthcare trended along with the broad market in Wednesday’s wide heavy-volume rally. The stock, with a market capitalization of $1.1 billion, is tracked by the S&P 600 Small Cap index, as well as the Russell 2000. 

Although large-cap indexes had a big day Wednesday, small caps actually outperformed. The SPDR S&P 500 ETF (NYSEARCA: SPY) was up 1.96%, while the SPDR Portfolio S&P 600 Small Cap ETF (NYSEARCA: SPSM) notched a gain of 2.68%. 

Outpacing Small-Cap Index

Cross Country Healthcare was up 4.03% for the session, its third day in a row of upside trade.

You can’t make too much of one upside day for the broader market, as bear-market rallies are common and you can even see some of the biggest gains during a bear. 

However, it’s always a good idea to track stocks like  Cross Country that are holding up better than most. The stock is flat relative to where it ended 2021, thanks to a lengthy correction that began in early January.

Shares are up 8.40% in the past month and up 36.88% in the past three months.

Cross Country tends to have wide intraday price swings, which is not uncommon with a small stock that has few shares in its float. In this case, the float totals just 36.3 million. That volatility can occur because the small number of shares available means buyers and sellers may have a difficult time finding someone at the other end of the trade. The wide swings mean there’s not always agreement on what the price should be. 

The stock has a beta of 1.14, meaning it’s slightly more volatile than the broad market. In this case, that’s translated to gains, but volatility can also result in greater share-price declines. 

That’s a possible negative about Cross Country. However, there are plenty of positive aspects to offset that drawback. For example, revenue grew between 53% and 127% in the past six quarters, while earnings grew at triple-digit rates for the past eight quarters. 
This Small-Cap Healthcare Name Is Outperforming Its Index

Long History Of Topping Analyst Views

MarketBeat earnings data for the stock show that Cross Country topped both earnings and revenue expectations in every quarter since July 2019. That kind of track record bodes well for future earnings and revenue beats.

Checking with analyst data compiled by MarketBeat, you’ll find that Wall Street has a “moderate buy” rating on the stock with a price target of $33.75, representing a 16.86% upside. 

Cross Country shares have been languishing somewhat below resistance near $30.50, where they got smacked down three times, once on July 21 and again on September 14 and 15. Watch for the stock to gather up the momentum to clear that hurdle, which would be a good sign of more gains to come. 

The company is set to grow through acquisition, as indicated by its September 13 announcement that it would acquire the assets of Mint Medical Physician Staffing and Lotus Medical Staffing. Lotus is an independent unit of Mint. The transaction is expected to close in the fourth quarter. 

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.